Cancer Metastasis
A section of Cancers (ISSN 2072-6694).
Section Information
Tumor metastasis is one of the hallmarks of cancer and is considered to be the main cause of death for most cancer patients. The process of metastasis is very complex as the characteristics of invading tumor cells are driven by various epigenetic and genetic changes. It is well known that the primary tumors are different than metastatic tumors, hence presenting challenges in treatment as most of the treatment is directed towards the primary tumor. What role immune cells play with invading metastatic tumor cells is not well understood. Therefore, understanding how the tumor microenvironment interacts and allows the invading tumor cells to establish at a distant site is important for unravelling the mechanism of metastasis. Thus, identifying potential molecular targets in the process of metastasis is critical before making any therapeutic interventions.
Keywords
- Tumor metastasis
- Tumor microenvironment
- Hypoxia
- Extravasation of tumor cells
- Tumor heterogeneity
- Tumor derived exosomes
- Cancer associated fibroblasts
- Angiogenesis
- Warburg effect
- Immune checkpoints
- Regulatory and suppressive immune cells
- Cancer therapeutics
- Targeted therapy
- Drug repurposing
- Drug resistance
- Cancer cell metabolism
- Combination therapy
- Metastasis models
- Extracellular matrix
- Metastasis related targets
- Biomarkers
- Clinical trials
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Chemotherapy and Treatment: Metastasis of Colorectal Cancer (Deadline: 20 November 2024)
- Breast Cancer Metastasis: Novel Insights into Molecular Mechanisms and Treatments (Deadline: 5 December 2024)
- Molecular Mechanisms of Cancer Development and Metastasis (Deadline: 20 December 2024)
- Pathophysiology, Diagnosis, and Multidisciplinary Management of Bone Metastases (Deadline: 31 December 2024)
- Novel Insights into Glioblastoma and Brain Metastases (Deadline: 31 December 2024)
- The Role of Epithelial-Mesenchymal Transition in Therapies Resistance and Cancer Metastasis (Deadline: 19 January 2025)
- Molecular Pathways in Metastasis of Lung Cancer (Deadline: 31 January 2025)
- Head and Neck Cancer Metastases (Deadline: 1 February 2025)
- Bone and Spine Metastases (Deadline: 10 February 2025)
- Recent Advance in Colorectal Cancer Liver Metastases (Deadline: 15 February 2025)
- Irreversible Electroporation for Liver Metastases from Colorectal Cancer (Deadline: 5 March 2025)
- Breast Cancer Brain Metastasis and Leptomeningeal Disease (Deadline: 15 March 2025)
- Thermal Ablation in the Management for Colorectal Liver Metastases (Deadline: 20 March 2025)
- Exosomes in Cancer Metastasis (Deadline: 31 March 2025)
- Cancer Cell Motility (Deadline: 31 March 2025)
- Advances in Locally Advanced and Metastatic Kidney Cancer (Deadline: 15 April 2025)
- Advances in Metastatic Prostate Cancer (Deadline: 21 April 2025)
- Brain Metastases: From Mechanisms to Treatment (Deadline: 30 April 2025)
- Metastasis Associated Long Noncoding RNAs in Cancer Research (Deadline: 20 May 2025)
- Lectins in Cancer (Deadline: 25 May 2025)
- Advances and Research Priorities for Metastatic-Hormone-Resistant Prostate Cancer (Deadline: 31 May 2025)
- The Role of Circulating Tumor Cells in Cancer Metastasis (Deadline: 30 June 2025)
- “Cancer Metastasis” in 2023–2024 (Deadline: 30 June 2025)
- Educating Recent Updates on Metastatic Non-small Cell Lung Cancer (Deadline: 30 June 2025)
- Regulators of Breast Cancer Metastasis (Deadline: 30 June 2025)
- Gastric Cancer Metastases (Deadline: 15 July 2025)
- Cancer Cells Fostered Microenvironment in Metastasis (Deadline: 30 July 2025)
- The Role of Neutrophils in Tumor Progression and Metastasis (Deadline: 30 July 2025)
- Heterogeneity in Intra-Cranial Tumors: Diagnostic, Prognostic, and Therapeutic Implications (Deadline: 31 July 2025)
- Oligometastases Hypothesis to Advancing New Perspectives on Cancer: Oligo-Reurrence (Deadline: 15 August 2025)
- Exploring the Interplay of Glioblastoma Angiogenesis, ROS, and Tumor Microenvironment: Advancements in Combination Therapy and Bioinformatics Approaches (Deadline: 31 August 2025)
- Cutaneous Metastases: State-of-the-Art Research and Management (Deadline: 15 October 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
